Yüklüyor......
Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
Approximately 25% of patients diagnosed with pancreatic cancer present with non-metastatic resectable or borderline resectable disease. Unfortunately, the cure rate for these “curable” patients is only in the range of 20%. Local-regional failure rates may exceed 50% after margin-negative, node-negat...
Kaydedildi:
| Yayımlandı: | World J Gastrointest Surg |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783690/ https://ncbi.nlm.nih.gov/pubmed/31602289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v11.i7.303 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|